cultivation systems, which will allow the control and supervision of cannabis plants using the latest technologies, developing them into quality plants suitable for supervised medical use according to the strict IMC-GAP standards of Israel’s Ministry of Health. The company is also in the process of adapting a pharmaceutical factory, which will meet all the required strict conditions for manufacturing medical products according to the IMC-GAP standard.